Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects.

Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M.

Clin Pharmacol Ther. 1999 Jul;66(1):76-84.

PMID:
10430112
[PubMed - indexed for MEDLINE]
2.

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.

Schwartz JI, Vandormael K, Malice MP, Kalyani RN, Lasseter KC, Holmes GB, Gertz BJ, Gottesdiener KM, Laurenzi M, Redfern KJ, Brune K.

Clin Pharmacol Ther. 2002 Jul;72(1):50-61.

PMID:
12152004
[PubMed - indexed for MEDLINE]
3.

Effects of celecoxib and naproxen on renal function in the elderly.

Whelton A, Schulman G, Wallemark C, Drower EJ, Isakson PC, Verburg KM, Geis GS.

Arch Intern Med. 2000 May 22;160(10):1465-70.

PMID:
10826459
[PubMed - indexed for MEDLINE]
4.

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL.

Ann Intern Med. 2000 Jul 4;133(1):1-9.

PMID:
10877734
[PubMed - indexed for MEDLINE]
5.

Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.

Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B.

J Hypertens. 2004 Jan;22(1):191-8.

PMID:
15106811
[PubMed - indexed for MEDLINE]
6.

Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects.

Dilger K, Herrlinger C, Peters J, Seyberth HW, Schweer H, Klotz U.

J Clin Pharmacol. 2002 Sep;42(9):985-94.

PMID:
12211224
[PubMed - indexed for MEDLINE]
7.

Role of cyclooxygenase-2 in the prolonged regulation of renal function.

Roig F, Llinás MT, López R, Salazar FJ.

Hypertension. 2002 Nov;40(5):721-8.

PMID:
12411468
[PubMed - indexed for MEDLINE]
Free Article
8.

Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.

Rodríguez F, Llinás MT, González JD, Rivera J, Salazar FJ.

Hypertension. 2000 Aug;36(2):276-81.

PMID:
10948090
[PubMed - indexed for MEDLINE]
Free Article
9.

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.

Huledal G, Jonzon B, Malmenäs M, Hedman A, Andersson LI, Odlind B, Brater DC.

Clin Pharmacol Ther. 2005 May;77(5):437-50.

PMID:
15900289
[PubMed - indexed for MEDLINE]
10.

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.

JAMA. 1999 Nov 24;282(20):1921-8.

PMID:
10580457
[PubMed - indexed for MEDLINE]
11.

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA.

J Pharmacol Exp Ther. 1999 May;289(2):735-41.

PMID:
10215647
[PubMed - indexed for MEDLINE]
Free Article
12.

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.

Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J.

Gastroenterology. 1999 May;116(5):1167-75.

PMID:
10220509
[PubMed - indexed for MEDLINE]
13.
14.

Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.

Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, Maxwell C, Palmisano J, Keaney JF Jr, Morrow JD, Vita JA.

Hypertension. 2003 Sep;42(3):310-5. Epub 2003 Jul 21.

PMID:
12874094
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.

Stichtenoth DO, Marhauer V, Tsikas D, Gutzki FM, Frölich JC.

Kidney Int. 2005 Nov;68(5):2197-207.

PMID:
16221219
[PubMed - indexed for MEDLINE]
16.

Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.

White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A.

Hypertension. 2002 Apr;39(4):929-34.

PMID:
11967252
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.

Izhar M, Alausa T, Folker A, Hung E, Bakris GL.

Hypertension. 2004 Mar;43(3):573-7. Epub 2004 Jan 26.

PMID:
14744921
[PubMed - indexed for MEDLINE]
Free Article
18.

Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.

Hermann M, Shaw S, Kiss E, Camici G, Bühler N, Chenevard R, Lüscher TF, Gröne HJ, Ruschitzka F.

Hypertension. 2005 Feb;45(2):193-7. Epub 2005 Jan 3.

PMID:
15630049
[PubMed - indexed for MEDLINE]
Free Article
19.

Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.

Harding P, Carretero OA, Beierwaltes WH.

J Hypertens. 2000 Aug;18(8):1107-13.

PMID:
10954003
[PubMed - indexed for MEDLINE]
20.

Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.

Fujihara CK, Antunes GR, Mattar AL, Andreoli N, Malheiros DM, Noronha IL, Zatz R.

Kidney Int. 2003 Dec;64(6):2172-81.

PMID:
14633140
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk